An antibiotic proposed as a treatment for acute sinus infections should be studied further because of serious skin reactions associated with its use, federal health officials said in documents released Monday. When compared with other antibiotics used to treat minor infections, the incident of serious rashes has Food and Drug Administration officials concerned about the safety of the drug, Factive or gemifloxacin.
Steve - many experts now believe from recent studies that chronic sinus infections or sinusitis are predominately fungal, not bacterial, then rendering antibiotics ineffective.
Monday, September 11, 2006
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment